{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T11:18:47Z","timestamp":1794136727138,"version":"4.8.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computers in Biology and Medicine"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.compbiomed.2024.107930","type":"journal-article","created":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T12:15:09Z","timestamp":1704370509000},"page":"107930","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Disulfidptosis-related lncRNA signatures assess immune microenvironment and drug sensitivity in hepatocellular carcinoma"],"prefix":"10.1016","volume":"169","author":[{"given":"Kequan","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caixia","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuqi","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinze","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiangen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.compbiomed.2024.107930_bib1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/hep.31288","article-title":"Epidemiology of hepatocellular carcinoma","volume":"73","author":"McGlynn","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.compbiomed.2024.107930_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.acr.2020.10.001","article-title":"Hepatocellular carcinoma (HCC): epidemiology, etiology and molecular classification","volume":"149","author":"Chidambaranathan-Reghupaty","year":"2021","journal-title":"Adv. Cancer Res."},{"issue":"3","key":"10.1016\/j.compbiomed.2024.107930_bib3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41571-021-00573-2","article-title":"Immunotherapies for hepatocellular carcinoma","volume":"19","author":"Llovet","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.compbiomed.2024.107930_bib4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41392-020-0187-x","article-title":"The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects","volume":"5","author":"Tang","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"11","key":"10.1016\/j.compbiomed.2024.107930_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22115801","article-title":"Tumor immune microenvironment and immunosuppressive therapy in hepatocellular carcinoma: a review","volume":"22","author":"Oura","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.compbiomed.2024.107930_bib6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.apsb.2020.09.016","article-title":"Recent advances in drug delivery systems for targeting cancer stem cells","volume":"11","author":"Duan","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.compbiomed.2024.107930_bib7","article-title":"Cuproptosis-related risk score predicts prognosis and characterizes the tumor microenvironment in hepatocellular carcinoma","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.compbiomed.2024.107930_bib8","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/jcmm.13008","article-title":"Ferroptosis, a new form of cell death, and its relationships with tumourous diseases","volume":"21","author":"Yu","year":"2017","journal-title":"J. Cell Mol. Med."},{"issue":"3","key":"10.1016\/j.compbiomed.2024.107930_bib9","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41556-023-01091-2","article-title":"Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis","volume":"25","author":"Liu","year":"2023","journal-title":"Nat. Cell Biol."},{"issue":"5","key":"10.1016\/j.compbiomed.2024.107930_bib10","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.tem.2023.02.007","article-title":"ncRNA-mediated fatty acid metabolism reprogramming in HCC","volume":"34","author":"Xu","year":"2023","journal-title":"Trends Endocrinol. Metabol."},{"key":"10.1016\/j.compbiomed.2024.107930_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101540","article-title":"A novel lncRNA RP11-386G11.10 reprograms lipid metabolism to promote hepatocellular carcinoma progression","volume":"63","author":"Xu","year":"2022","journal-title":"Mol. Metabol."},{"issue":"4","key":"10.1016\/j.compbiomed.2024.107930_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagrm.2019.194419","article-title":"The how and why of lncRNA function: an innate immune perspective","volume":"1863","author":"Robinson","year":"2020","journal-title":"Biochim. Biophys. Acta Gene. Regul. Mech."},{"key":"10.1016\/j.compbiomed.2024.107930_bib13","article-title":"A novel disulfidptosis-associated expression pattern in breast cancer based on machine learning","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Genet."},{"issue":"1","key":"10.1016\/j.compbiomed.2024.107930_bib14","article-title":"The disulfidptosis-related signature predicts prognosis and immune features in glioma patients","volume":"13","author":"Wang","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.compbiomed.2024.107930_bib15","article-title":"Leveraging a disulfidptosis-based signature to improve the survival and drug sensitivity of bladder cancer patients","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.compbiomed.2024.107930_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2023.107402","article-title":"Identification of a disulfidptosis-related genes signature for prognostic implication in lung adenocarcinoma","volume":"165","author":"Huang","year":"2023","journal-title":"Comput. Biol. Med."},{"issue":"1","key":"10.1016\/j.compbiomed.2024.107930_bib17","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s10020-023-00739-x","article-title":"Leveraging a disulfidptosis-related signature to predict the prognosis and immunotherapy effectiveness of cutaneous melanoma based on machine learning","volume":"29","author":"Zhao","year":"2023","journal-title":"Mol. Med."},{"key":"10.1016\/j.compbiomed.2024.107930_bib18","article-title":"Exploration of epithelial-mesenchymal transition-related lncRNA signature and drug sensitivity in breast cancer","volume":"14","author":"Li","year":"2023","journal-title":"Front. Endocrinol."},{"issue":"6","key":"10.1016\/j.compbiomed.2024.107930_bib19","doi-asserted-by":"crossref","first-page":"7667","DOI":"10.1002\/cam4.5500","article-title":"Development of the expression and prognostic significance of m(5) C-related LncRNAs in breast cancer","volume":"12","author":"Xu","year":"2023","journal-title":"Cancer Med."},{"issue":"10","key":"10.1016\/j.compbiomed.2024.107930_bib20","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.7150\/ijbs.69495","article-title":"A positive feedback loop of CENPU\/E2F6\/E2F1 facilitates proliferation and metastasis via ubiquitination of E2F6 in hepatocellular carcinoma","volume":"18","author":"Liu","year":"2022","journal-title":"Int. J. Biol. Sci."},{"issue":"5","key":"10.1016\/j.compbiomed.2024.107930_bib21","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1053\/j.gastro.2023.01.033","article-title":"Global epidemiology and genetics of hepatocellular carcinoma","volume":"164","author":"Toh","year":"2023","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.compbiomed.2024.107930_bib22","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41575-021-00438-0","article-title":"Advances in immunotherapy for hepatocellular carcinoma","volume":"18","author":"Sangro","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.compbiomed.2024.107930_bib23","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13062-023-00358-w","article-title":"Identification of a prognostic cuproptosis-related signature in hepatocellular carcinoma","volume":"18","author":"Chen","year":"2023","journal-title":"Biol. Direct"},{"issue":"1","key":"10.1016\/j.compbiomed.2024.107930_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-25356-2","article-title":"A six lipid metabolism related gene signature for predicting the prognosis of hepatocellular carcinoma","volume":"12","author":"Xu","year":"2022","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.compbiomed.2024.107930_bib25","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s13402-022-00707-3","article-title":"Heterogeneity, inherent and acquired drug resistance in patient-derived organoid models of primary liver cancer","volume":"45","author":"Xian","year":"2022","journal-title":"Cell. Oncol."},{"issue":"1","key":"10.1016\/j.compbiomed.2024.107930_bib26","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1158\/0008-5472.CAN-22-0963","article-title":"METTL1-Mediated m7G tRNA modification promotes lenvatinib resistance in hepatocellular carcinoma","volume":"83","author":"Huang","year":"2023","journal-title":"Cancer Res."}],"container-title":["Computers in Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482524000143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482524000143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T21:03:40Z","timestamp":1720559020000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010482524000143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":26,"alternative-id":["S0010482524000143"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiomed.2024.107930","relation":{},"ISSN":["0010-4825"],"issn-type":[{"value":"0010-4825","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disulfidptosis-related lncRNA signatures assess immune microenvironment and drug sensitivity in hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Computers in Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiomed.2024.107930","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107930"}}